TapewireFind a company

person · Reporting owner

PRYOR DANIEL A

Disclosed activity across 2 companies

Tapewire entity
17533
SEC CIK
0001205249

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DANAHER CORP /DE/DHR · Entity 2871VP-Strategic DevelopmentMay 04, 2005May 06, 2005

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DANAHER CORP /DE/

Report date May 04, 2005 · Filed May 06, 2005

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Performance based restricted stock unitsSEC Table II · derivative / convertible security · Expires 2014-05-04Direct20,000 Reported balance After 2005-05-04 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2005-05-04 · Grant · Acquired 20,000 · Balance 20,000

F1: Each performance based restricted stock unit represents a right to receive one share of Company Common Stock.

F2: On May 4, 2004, the Compensation Committee of the Company's Board of Directors awarded the reporting person 20,000 performance based restricted stock units. These restricted stock units vest (1) 50% upon the fourth anniversary of the grant date and 50% upon the fifth anniversary of the grant date, and (2) upon the satisfaction of specified performance criteria. This Form 4 is being filed in connection with the determination by the Compensation Committee of the Board of Directors that the performance criteria of the award have been achieved.

Filing footnotes · ownership attribution and instrument terms

F1: Each performance based restricted stock unit represents a right to receive one share of Company Common Stock.

F2: On May 4, 2004, the Compensation Committee of the Company's Board of Directors awarded the reporting person 20,000 performance based restricted stock units. These restricted stock units vest (1) 50% upon the fourth anniversary of the grant date and 50% upon the fifth anniversary of the grant date, and (2) upon the satisfaction of specified performance criteria. This Form 4 is being filed in connection with the determination by the Compensation Committee of the Board of Directors that the performance criteria of the award have been achieved.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Enovis CORP

Report date December 09, 2025 · Filed December 12, 2025

Section 16 reporting ended · disclosed 2025-12-12. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common stock, par value $0.001SEC Table I · non-derivativeDirect160,449 Reported balance After 2025-12-09 transaction · row 1
1 source row

Row 1 · 2025-12-09 · Sale · Disposed 666 · Balance 160,449

Common stock, par value $0.001SEC Table I · non-derivativeIndirectBy trust for daughter0 Reported balance After 2025-12-09 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 2 · 2025-12-09 · Sale · Disposed 333 · Balance 0

Common stock, par value $0.001SEC Table I · non-derivativeIndirectBy trust for daughter0 Reported balance After 2025-12-09 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 3 · 2025-12-09 · Sale · Disposed 333 · Balance 0

Common stock, par value $0.001SEC Table I · non-derivativeIndirectBy trust for son0 Reported balance After 2025-12-09 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 4 · 2025-12-09 · Sale · Disposed 333 · Balance 0

Common stock, par value $0.001SEC Table I · non-derivativeIndirectBy 401k plan932 Reported balance Holding disclosure · report date 2025-12-09 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 932

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 09, 2025 Filed Dec 12, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 333 $27.22 $9,064.26
Disclosure

SEC source: 0001193125-25-316574 · ownership.xml · nonDerivative · entry 4

PRYOR DANIEL A · CIK 0001205249 · Former EVP, Strategy & Bus Dev

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust for son

Disclosed balance after: 0

Read SEC document
December 09, 2025 Filed Dec 12, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 333 $27.18 $9,050.94
Disclosure

SEC source: 0001193125-25-316574 · ownership.xml · nonDerivative · entry 3

PRYOR DANIEL A · CIK 0001205249 · Former EVP, Strategy & Bus Dev

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust for daughter

Disclosed balance after: 0

Read SEC document
December 09, 2025 Filed Dec 12, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 333 $27.21 $9,060.93
Disclosure

SEC source: 0001193125-25-316574 · ownership.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · Former EVP, Strategy & Bus Dev

10b5-1 filing: No plan indicated

Ownership: Indirect · By trust for daughter

Disclosed balance after: 0

Read SEC document
December 09, 2025 Filed Dec 12, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 666 $27.21 $18,121.86
Disclosure

SEC source: 0001193125-25-316574 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · Former EVP, Strategy & Bus Dev

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,449

Read SEC document
August 13, 2025 Filed Aug 14, 2025 20:05 UTC Enovis CORP ENOV · Entity 4797 PurchaseCommon stock, par value $0.001 10,000 $28.90 $289,000.00
Disclosure

SEC source: 0001205249-25-000003 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,115

Read SEC document
March 07, 2025 Filed Mar 12, 2025 01:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 24,137 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-037571 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,115

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 04, 2025 Filed Mar 7, 2025 02:05 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 2,331 $36.62 $85,361.22
Disclosure

SEC source: 0000950170-25-035074 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,978

F1 · shares: Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 4,998 $38.65 $193,172.70
Disclosure

SEC source: 0000950170-25-032841 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,309

F1 · shares: Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of PRSUs and time-based restricted stock units and does not represent a sale by the reporting person.

Read SEC document
February 17, 2025 Filed Feb 20, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 6,599 $43.89 $289,630.11
Disclosure

SEC source: 0000950170-25-023644 · ownership.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,307

F2 · shares: Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of PRSUs and time-based restricted stock units and does not represent a sale by the reporting person.

Read SEC document
February 17, 2025 Filed Feb 20, 2025 02:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 13,793 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-023644 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,906

F1 · shares: Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2022. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2023 Fiscal Year-End" table on page 44 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 5, 2024.

Read SEC document
March 06, 2024 Filed Mar 7, 2024 02:00 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 1,728 $61.84 $106,859.52
Disclosure

SEC source: 0000950170-24-027533 · ownership.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,113

F2 · shares: Represents shares that have been withheld by the Company to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.

Read SEC document
March 04, 2024 Filed Mar 7, 2024 02:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 16,121 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-027533 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,841

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:30 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 1,200 $59.81 $71,772.00
Disclosure

SEC source: 0000950170-24-026793 · ownership.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,720

F1 · shares: Represents shares that have been withheld by the Company to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 02:30 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 530 $59.81 $31,699.30
Disclosure

SEC source: 0000950170-24-026793 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,920

F1 · shares: Represents shares that have been withheld by the Company to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 00:00 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 6,514 $63.80 $415,593.20
Disclosure

SEC source: 0000950170-24-020446 · ownership.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,450

F2 · shares: Represents shares that have been withheld by the Company to satisfy its tax withholding and remittance obligations in connection with the net settlement of certain restricted stock units and performance-based restricted stock units and does not represent a sale by the reporting person.

Read SEC document
February 22, 2024 Filed Feb 27, 2024 00:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 13,616 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-020446 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,964

F1 · shares: Reflects the certification of the performance criteria for PRSUs previously awarded in 2021. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2022 Fiscal Year-End" table on page 44 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on March 31, 2023.

Read SEC document
February 20, 2024 Filed Feb 22, 2024 23:00 UTC Enovis CORP ENOV · Entity 4797 Tax withholdingCommon stock, par value $0.001 943 $59.29 $55,910.47
Disclosure

SEC source: 0000950170-24-018967 · ownership.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,348

F1 · shares: Represents shares that have been withheld by the Company to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.

Read SEC document
March 06, 2023 Filed Mar 9, 2023 01:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 1,898 $57.69 $109,495.62
Disclosure

SEC source: 0001209191-23-017397 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,291

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 01:00 UTC Enovis CORP ENOV · Entity 4797 GrantEmployee Stock Option (right to buy) · Derivative 18,642 $0.00 Strike: $57.62 $0.00
Disclosure

SEC source: 0001209191-23-014366 · doc4.xml · derivative · entry 9

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,642

Underlying: Common stock, par value $0.001 · 18,642 shares

Expires 2030-02-27

F4 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 01:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 24,190 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014366 · doc4.xml · nonDerivative · entry 4

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,189

F3 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 01:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 7,862 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014366 · doc4.xml · nonDerivative · entry 3

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,999

F3 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 27, 2023 Filed Mar 2, 2023 01:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 5,716 $56.08 $320,553.28
Disclosure

SEC source: 0001209191-23-014366 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,137

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units.

F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units.

Read SEC document
February 27, 2023 Filed Mar 2, 2023 01:00 UTC Enovis CORP ENOV · Entity 4797 GrantCommon stock, par value $0.001 10,341 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014366 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,853

F1 · kind: Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022.

F1 · shares: Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022.

Read SEC document
February 23, 2023 Filed Feb 24, 2023 01:01 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 1,113 $54.61 $60,780.93
Disclosure

SEC source: 0001209191-23-012403 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,512

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
February 21, 2023 Filed Feb 24, 2023 01:01 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 1,106 $62.11 $68,693.66
Disclosure

SEC source: 0001209191-23-012403 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,625

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:00 UTC Enovis CORP ENOV · Entity 4797 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 67,421 $0.00 Strike: $45.06 $0.00
Disclosure

SEC source: 0001209191-22-057656 · doc4.xml · derivative · entry 7

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock, par value $.001 · 67,421 shares

Expires 2023-11-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 11/15/2015

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:00 UTC Enovis CORP ENOV · Entity 4797 SaleCommon stock, par value $0.001 67,421 $54.58 $3,679,568.50
Disclosure

SEC source: 0001209191-22-057656 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,731

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $55.01, inclusive. The reporting person undertakes to provide to Enovis Corporation, any security holder of Enovis Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 15, 2022 Filed Nov 17, 2022 23:00 UTC Enovis CORP ENOV · Entity 4797 Exercise / conversionCommon stock, par value $0.001 67,421 $45.06 $3,037,990.26
Disclosure

SEC source: 0001209191-22-057656 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 3,463 $38.88 $134,641.44
Disclosure

SEC source: 0001209191-22-017660 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,175

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 00:01 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 31,274 $41.18 $1,287,894.59
Disclosure

SEC source: 0001209191-22-014361 · doc4.xml · nonDerivative · entry 3

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,638

F1 · kind: The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").

F1 · shares: The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").

Read SEC document
February 25, 2022 Filed Mar 2, 2022 00:01 UTC Enovis CORP CFX · Entity 4797 GrantCommon stock, par value $.001 62,821 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-014361 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,912

F2 · kind: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021.

F2 · shares: Reflects the certification of the performance criteria for PRSUs previously awarded in 2019. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2020 Fiscal Year-End" table on page 42 of Colfax Corporation's 2021 Proxy Statement as filed with the Securities and Exchange Commission on April 1, 2021.

Read SEC document
February 25, 2022 Filed Mar 2, 2022 00:01 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 2,024 $42.18 $85,372.32
Disclosure

SEC source: 0001209191-22-014361 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,091

F1 · kind: The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").

F1 · shares: The sales reported in this Form 4 were effected to meet tax obligations relating to the vesting and delivery of certain restricted stock units and performance-based restricted stock units ("PRSUs").

Read SEC document
February 23, 2022 Filed Feb 25, 2022 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 1,866 $41.83 $78,054.78
Disclosure

SEC source: 0001209191-22-013297 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.

Read SEC document
February 17, 2022 Filed Feb 23, 2022 00:00 UTC Enovis CORP CFX · Entity 4797 GrantEmployee Stock Option (right to buy) · Derivative 31,031 $0.00 Strike: $41.70 $0.00
Disclosure

SEC source: 0001209191-22-011933 · doc4.xml · derivative · entry 6

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,031

Underlying: Common stock, par value $.001 · 31,031 shares

Expires 2029-02-17

F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 17, 2022 Filed Feb 23, 2022 00:00 UTC Enovis CORP CFX · Entity 4797 GrantCommon stock, par value $.001 11,724 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011933 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,981

F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 23:59 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 556 $0.00 Strike: $52.02 $0.00
Disclosure

SEC source: 0001209191-21-063956 · doc4.xml · derivative · entry 7

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,209

Underlying: Common stock, par value $.001 · 556 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 23:59 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 556 $53.03 $29,486.35
Disclosure

SEC source: 0001209191-21-063956 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,257

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.25, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 23:59 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionCommon stock, par value $.001 556 $52.02 $28,923.12
Disclosure

SEC source: 0001209191-21-063956 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 7,289 $0.00 Strike: $52.02 $0.00
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · derivative · entry 14

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,765

Underlying: Common stock, par value $.001 · 7,289 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 90 $54.08 $4,867.20
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 8

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,257

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 6,045 $54.22 $327,778.04
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 7

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,347

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F6 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.04 to $54.43, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 1,154 $53.44 $61,667.45
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 6

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,392

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F5 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.94, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.

Read SEC document
November 05, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionCommon stock, par value $.001 7,289 $52.02 $379,173.78
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 5

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,546

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 16,616 $0.00 Strike: $52.02 $0.00
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · derivative · entry 13

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,054

Underlying: Common stock, par value $.001 · 16,616 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 300 $54.14 $16,242.90
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 4

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,257

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F4 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.10 to $54.19, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 12,955 $54.09 $700,723.00
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 3

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,557

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.22, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 3,361 $53.59 $180,109.27
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,512

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.08 to $54.02, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document
November 04, 2021 Filed Nov 8, 2021 23:00 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionCommon stock, par value $.001 16,616 $52.02 $864,364.32
Disclosure

SEC source: 0001209191-21-063437 · doc4.xml · nonDerivative · entry 1

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,873

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 02, 2021 Filed Nov 4, 2021 22:00 UTC Enovis CORP CFX · Entity 4797 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 6,340 $0.00 Strike: $52.02 $0.00
Disclosure

SEC source: 0001209191-21-062991 · doc4.xml · derivative · entry 7

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,670

Underlying: Common stock, par value $.001 · 6,340 shares

Expires 2022-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.

Read SEC document
November 02, 2021 Filed Nov 4, 2021 22:00 UTC Enovis CORP CFX · Entity 4797 SaleCommon stock, par value $.001 6,340 $53.02 $336,153.14
Disclosure

SEC source: 0001209191-21-062991 · doc4.xml · nonDerivative · entry 2

PRYOR DANIEL A · CIK 0001205249 · EVP, Strategy & Business Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,257

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.06, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.